Ovid Application Error
A Phase II Safety and Efficacy Study on Prognosis of Moderate Pneumonia in Coronavirus Disease 2019 Patients With Regular Intravenous Immunoglobulin Therapy. Raman, R S; Bhagwan Barge, Vijaykumar; Anil Kumar, Darivenula; Dandu, Himanshu; Rakesh Kartha, R; Bafna, Varun; Aravinda, Vishaly T; Raghuram, Thummala C [Article] Journal of Infectious Diseases. 223(9):1538-1543, May 01, 2021.
(Format: HTML, PDF)